Sidera Bio
PrivateLast Round
Series A
Dec 9, 2025
Total Funding Raised
$109M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sidera Bio operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Series A round in December 2025.
Sidera Bio is a biotechnology company that develops genetics-driven cardiometabolic therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sidera Bio Comparables
Compare Sidera Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verdiva Bio | 84% | |
| Antag Therapeutics | 84% | |
| Kailera Therapeutics | 78% |
For institutional investors. Book with your work email.
Sidera Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Sidera Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Forbion | Series A |
| Gilde Healthcare | Series A |
| Novo Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 56% to 3,000.
- Jun 19, 2026
Monthly visitors increased 541% MoM.
For institutional investors. Book with your work email.
Sidera Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sidera Bio's valuation, stock price, and market status.
Is Sidera Bio a public or private company?
Sidera Bio is a private company.
What is the current stock price of Sidera Bio?
Sidera Bio is a private company, so its shares have no public market price. Caplight tracks Sidera Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sidera Bio worth (valuation)?
Valuation information for Sidera Bio is not publicly available.
Can I buy Sidera Bio stock?
Sidera Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sidera Bio's last funding round?
Sidera Bio's most recent funding round was Series A on December 9, 2025.
Who are the main investors in Sidera Bio?
Key investors in Sidera Bio include RA Capital Management, Forbion, Gilde Healthcare, Novo Holdings.
Will Sidera Bio IPO soon?
No public IPO plans have been announced for Sidera Bio.
How can I track Sidera Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sidera Bio's shares on secondary markets.